<?xml version="1.0" encoding="UTF-8"?>
	<rss version="2.0"
		xmlns:content="http://purl.org/rss/1.0/modules/content/"
		xmlns:wfw="http://wellformedweb.org/CommentAPI/"
		xmlns:dc="http://purl.org/dc/elements/1.1/"
		xmlns:atom="http://www.w3.org/2005/Atom"

			>

	<channel>
		<title>Nedrago Games  &#187;  Topic: The Challenge of Global Health Equity</title>
		<atom:link href="https://www.nedrago.com/forums/topic/the-challenge-of-global-health-equity/feed/" rel="self" type="application/rss+xml" />
		<link>https://www.nedrago.com/forums/topic/the-challenge-of-global-health-equity/feed/</link>
		<description></description>
		<pubDate>Wed, 08 Jul 2026 01:26:38 +0000</pubDate>
		<generator>http://bbpress.org/?v=2.5.7-5693</generator>
		<language>en-US</language>

		
														
					
				<item>
					<guid>https://www.nedrago.com/forums/topic/the-challenge-of-global-health-equity/#post-176452</guid>
					<title><![CDATA[The Challenge of Global Health Equity]]></title>
					<link>https://www.nedrago.com/forums/topic/the-challenge-of-global-health-equity/#post-176452</link>
					<pubDate>Thu, 04 Dec 2025 02:34:32 +0000</pubDate>
					<dc:creator>onlineservi</dc:creator>

					<description>
						<![CDATA[
						<p>Despite breathtaking medical advances, a central and enduring challenge is ensuring equitable access to healthcare innovations worldwide. The disparity in medical resources between high-income and low-income nations is stark, often described as the &#8220;10/90 gap,&#8221; where less than 10% of global health research funding addresses diseases that affect 90% of the world&#8217;s population. Diseases of poverty, such as tuberculosis and malaria, remain prevalent in regions lacking robust healthcare infrastructure, while cutting-edge treatments for cancer or rare genetic disorders carry prohibitive price tags. Achieving true progress in medicine therefore requires not only scientific brilliance but also a sustained commitment to ethical distribution, affordable pricing models, and the strengthening of primary care systems to ensure that lifesaving discoveries benefit all of humanity, not just a privileged few.</p>
						]]>
					</description>

					
					
				</item>

			
				<item>
					<guid>https://www.nedrago.com/forums/topic/the-challenge-of-global-health-equity/#post-176454</guid>
					<title><![CDATA[Reply To: The Challenge of Global Health Equity]]></title>
					<link>https://www.nedrago.com/forums/topic/the-challenge-of-global-health-equity/#post-176454</link>
					<pubDate>Thu, 04 Dec 2025 02:55:16 +0000</pubDate>
					<dc:creator>onlineservi</dc:creator>

					<description>
						<![CDATA[
						<p>Weight management treatments have evolved rapidly in recent years, and Singapore has seen a growing interest in innovative prescription options that support individuals on their weight-loss journeys. Among these advanced solutions is Mounjaro, a medication containing the active ingredient tirzepatide. Known for its dual-action mechanism and clinically studied effects, Mounjaro has become a preferred choice for many patients seeking medical support for weight management under proper supervision. We will also highlight the widely used <a href="https://www.doctoroncall.com/sg/pharmacy/prescription-medicine/mounjaro-25mgdose-kwikpen-solution-for-injection-in-pre-filled-pen-1s" rel="nofollow">Mounjaro 2.5mg/dose KwikPen Solution for Injection in Pre-filled Pen</a>, which is commonly prescribed as a starting dose for patients beginning their treatment.</p>
						]]>
					</description>

					
					
				</item>

					
		
	</channel>
	</rss>

